Featured Full-Length & Multi-Omics Solutions
Pioneering transcriptomics platforms engineered for high precision, complete isoform discovery, and single-cell resolution.
Why Choose BMKGene in Istanbul?
Combining cutting-edge long-read sequencing technology with localized support for research institutes across Marmara and greater Türkiye.
Direct sequencing of intact mRNA molecules from 5' to 3' poly-A tail without transcript assembly.
Jointly built with PerkinElmer, delivering ultra-high throughput NGS/SMRT library preparation.
Collaborations spanning 84+ regions worldwide, customized for Istanbul's booming bio-clusters.
Supercomputing backend boasting 4,260 cores and 121.7+ TFLOPS for immediate data interpretation.
Full-Length mRNA-Seq: Transforming Life Science Research in Istanbul
As Istanbul solidifies its position as a primary biotechnology hub connecting Europe and Asia, the demand for high-precision genomic tools has accelerated exponentially. Among modern multi-omics strategies, Full-Length mRNA Sequencing (Full-Length mRNA-Seq) represents a monumental paradigm shift over traditional short-read RNA sequencing techniques.
Traditional Next-Generation Sequencing (NGS) platforms fragment RNA transcripts into short pieces (150–300 bp), requiring complex bioinformatic algorithms to reconstruct full transcripts. This fragmentation process often fails to accurately identify complex alternative splicing isoforms, novel gene fusions, long non-coding RNAs (lncRNAs), and subtle polyadenylation (poly-A) tail dynamics. Full-length mRNA sequencing—leveraging Pacific Biosciences (PacBio SMRT) and Oxford Nanopore Technologies (ONT)—sequences entire intact mRNA transcripts from 5' ends directly to 3' poly-A tails without assembly.
For researchers, clinical institutions, and agricultural innovators in Istanbul, Biomarker Technologies (BMKGene) delivers state-of-the-art Full-Length mRNA-Seq products tailored to complex eukaryotic genomes, non-model organisms, and challenging biomedical samples.
Biotechnology Landscape & Localized Ecosystem in Istanbul
Istanbul stands as the vibrant economic and scientific heart of Türkiye, hosting world-class universities, technoparks, and medical research centers. Over the past decade, national initiatives such as TÜBİTAK (The Scientific and Technological Research Council of Türkiye) funding programs and regional development plans have catalyzed rapid growth across the Marmara region's life sciences sector.
1. Biomedical Research & Translational Medicine
Istanbul is home to renowned research hubs including Istanbul University, ITU ARI Teknokent, Koç University Research Center for Translational Medicine (KUTTAM), Sabancı University Nanotechnology Research and Application Center (SUNUM), and Bezmialem Vakıf University. Local oncologists and geneticists rely on full-length transcriptomics to discover novel biomarker signatures, decipher cancer splice variants, and design personalized immunotherapies tailored to the Anatolian genetic background.
2. Agricultural Biotechnology & Anatolian Crop Improvement
Beyond human health, Türkiye is a global agricultural power. Surrounding agricultural hubs rely on research teams in Istanbul to optimize crop resilience against drought, salinity, and pathogens. Full-length mRNA sequencing is critical for characterizing non-model plants—such as local varieties of wheat, figs, olives, hazelnuts, and endemic medicinal flora—where high-quality reference genomes are incomplete or unavailable.
3. Industrial Enzymes & Synthetic Biology
Istanbul's industrial technoparks are actively developing bio-based solutions for pharmaceuticals, textiles, and green energy. Full-length mRNA-Seq allows industrial microbiologists to map microbial gene networks, identifying novel enzymes and pathways for metabolic engineering and biomanufacturing.
Core Technical Advantages & Key Applications
Key Technological Superiorities
- Accurate Alternative Splicing (AS) Detection: Resolves exon-skipping, alternative promoters, and intron retention with single-molecule accuracy.
- Fusion Gene Identification: Uncovers complex chromosomal rearrangements in tumor samples without false-positive computational chimeras.
- Alternative Polyadenylation (APA) Site Mapping: Identifies 3' UTR variations that control gene expression and mRNA stability.
- Non-Reference Transcriptome Assembly: Constructs complete, full-length transcripts for species lacking reference genome sequences.
- Allele-Specific Expression Analysis: Discriminates parental allele expression patterns in heterozygous organisms.
Localized Case Scenarios in Türkiye
Oncology Biomarker Profiling: Researchers at clinical centers across Istanbul use BMKGene’s PacBio Iso-Seq pipeline to analyze alternative splicing in breast, lung, and colorectal cancers. This enables the discovery of neoantigens for therapeutic vaccine design.
Neuroscience & Single-Cell Transcriptomics: Complex brain tissue studies benefit greatly from combining single-nucleus RNA sequencing (snRNA-Seq) with long-read technologies, unraveling cellular heterogeneity in neurodegenerative disorders.
About Biomarker Technologies (BMKGene)
Biomarker Technologies (BMKGene), founded in 2009, is a premier global genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and over 200 software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
State-of-the-Art Multi-Level Platforms
BMKGene operates an infrastructure equipped with industry-leading platforms:
- PacBio Platforms: Sequel II, Sequel, RSII
- Nanopore Platforms: PromethION P48, GridION X5, MinION
- 10X Genomics: 10X ChromiumX, 10X Chromium Controller
- Illumina Platforms: NovaSeq
- BGI-Sequencing Platforms: DNBSEQ-G400, DNBSEQ-T7
- Bionano Irys System
- Mass Spectrometry: Waters XEVO G2-XS QTOF, QTRAP 6500+
Over 20,000 Square Feet Facility
Standard sample extraction, library construction cleanrooms, and high-throughput sequencing labs operating under strict SOPs.
Fully Automated Platform for Next-Generation Sequencing: Brilliant Lab 1000
Biomarker Technologies (BMKGene) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to high-throughput NGS library construction services.
BMKGene strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, providing customers in Istanbul and worldwide with superior sequencing services.
Advanced Laboratory & Manufacturing Facilities
Enterprise Qualifications & Intellectual Property
Enterprise Qualification — Rigorous international quality certifications and patent portfolio.
Explore Our Complete Product Portfolio
Comprehensive multi-omics sequencing tools for researchers in Istanbul and globally.
